序号 |
标题 |
次数 |
作者 |
发布时间 |
74836 |
DOTA缀合的TMVP1肽 DOTA-TMVP1 |
64 |
h |
2024-12-19 |
74837 |
DOTA-NHS-ester偶联16-氨基-1-十六烷硫醇盐酸盐 |
84 |
h |
2024-12-19 |
74838 |
DOTA-ST8950 DOTA偶联碘代氨基酸的类似物ST8950 |
85 |
h |
2024-12-19 |
74839 |
DOTA官能化酞菁纳米点 DOTA‐Functionalized Phthalocyanine Nanodots |
82 |
h |
2024-12-19 |
74840 |
DOTA-D-Phe1-Tyr3-octreotide preparations |
68 |
h |
2024-12-19 |
74841 |
DOTA-4Py 螯合剂DOTA偶联吡啶基4Py |
71 |
h |
2024-12-19 |
74842 |
钆喷酸葡胺(Gd-BOPTA) |
190 |
h |
2024-12-19 |
74843 |
DOTA-SA-mAb |
76 |
h |
2024-12-19 |
74844 |
(LLP2A-DOTA)(4)PEG(10000) |
72 |
h |
2024-12-19 |
74845 |
LLP2A-DOTA-聚乙二醇 LLP2A-DOTA-PEG |
68 |
h |
2024-12-19 |
74846 |
DOTA-AaLS/HER2Afb HER2Afb修饰DOTA缀合的AaLS-ST |
85 |
h |
2024-12-19 |
74847 |
DOTA-P4 Thz-Phe-D-Trp-Lys-Thr-DOTA DOTA的线型超短肽缀合物 |
95 |
h |
2024-12-19 |
74848 |
DOTA-BP DOTA偶联双膦酸盐 |
119 |
h |
2024-12-19 |
74849 |
DOTA缀合的p160肽基放射缀合物 DOTA-p160 |
97 |
h |
2024-12-19 |
74850 |
DOTA-氮氧化合物 DOTA-NOx |
84 |
h |
2024-12-19 |
74851 |
Er-DOTA 铒-DOTA配合物 |
88 |
h |
2024-12-19 |
74852 |
DOTA-SETSKSF DOTA偶联七个氨基酸残基组成的环肽抑制剂 |
133 |
h |
2024-12-19 |
74853 |
羧基Bn-DOTA p-COOH-Bn-DOTA |
81 |
h |
2024-12-19 |
74854 |
DOTA四酰肼钆(ⅲ)配合物 |
80 |
h |
2024-12-19 |
74855 |
3-Gd(III)-氨基乙基酰胺基-DOTA的缀合物 |
108 |
h |
2024-12-19 |
74856 |
TCO功能化的CC49抗体 TCO-CC49 |
176 |
h |
2024-12-19 |
74857 |
CLT1肽靶向Gd(III)螯合物 CLT1-dL-(Gd-DOTA) |
103 |
h |
2024-12-19 |
74858 |
DOTA-pNO(2)-Phe-c(DCys-Tyr-DTrp-Lys-Thr-Cys)DTyrNH |
121 |
h |
2024-12-19 |
74859 |
Gd-DOTA-PLGA-b-PEG 钆-四氮杂环十二烷四乙酸共轭的聚(乳酸-共-乙醇酸)-嵌段-聚(乙二醇)共聚物胶束 |
117 |
h |
2024-12-19 |
74860 |
DOTA聚乙二醇化星形共聚物纳米粒子 |
86 |
h |
2024-12-19 |
74861 |
镓-1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸-Ser-Ser-Ser-Leu-Thr-Val-Ser-Pro-Trp-Tyr |
109 |
h |
2024-12-19 |
74862 |
DOTA-C595 p-SCN-Bn-DOTA偶联C595抗体 |
139 |
h |
2024-12-19 |
74863 |
DOTA-Tyr3-奥曲肽 DOTA-Tyr3-TOC |
84 |
h |
2024-12-19 |
74864 |
DOTA-生物素-亲和素 DOTA-biotin-avidin |
60 |
h |
2024-12-19 |
74865 |
DOTA-AuNPs 螯合剂DOTA包覆金纳米颗粒 |
98 |
h |
2024-12-19 |
74866 |
PS-WSCS-DOTA-BBN 水溶性壳聚糖缀合的DOTA-铃蟾肽包覆的金纳米颗粒 |
78 |
h |
2024-12-19 |
74867 |
苄基DOTA Bn-DOTA |
185 |
h |
2024-12-19 |
74868 |
DOTA-LM3 生长抑素受体(SSTR)拮抗剂 |
101 |
h |
2024-12-19 |
74869 |
Ga-DOTA-MGS5 大环配体-靶向肽 |
98 |
h |
2024-12-19 |
74870 |
Re-cyc-DOTA-sst2-ANT复合物 |
97 |
h |
2024-12-19 |
74871 |
DOTA-SP DOTA-P物质(SP) |
105 |
h |
2024-12-19 |
74872 |
DOTA-MG45 DOTA偶联迷你胃泌素(MG45) |
100 |
h |
2024-12-19 |
74873 |
DOTA-甘露糖胺葡聚糖 DOTA-MADs |
84 |
h |
2024-12-19 |
74874 |
ICG-DOTA 大环配体DOTA修饰吲哚菁绿荧光染料 |
102 |
h |
2024-12-18 |
74875 |
DOTA-SSA 1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA)-生长抑素类似物(SSA) |
82 |
h |
2024-12-18 |
74876 |
DOTA螯合剂修饰[cPP(1-7) |
142 |
h |
2024-12-18 |
74877 |
DOTA-ALB-24 DOTA-4-(对碘苯基)丁酸酯-24 |
94 |
h |
2024-12-18 |
74878 |
DOTA-GGNle-CycMSH hex DOTA偶联新肽 |
110 |
h |
2024-12-18 |
74879 |
Zr-p-NO2Bn-DOTA异构体 锆-硝基苄基偶联DOTA螯合剂 |
106 |
h |
2024-12-18 |
74880 |
DOTA-PSMA-617 1,4,7,10-四氮杂环十五烷偶联PSMA-617 |
81 |
h |
2024-12-18 |